(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RNAZOL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

RNAZOL

ST13

US500000074538547

Class

1

Filing

74538547

Registration

1910953

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

24

Latest update

08/19/2026

Trademark type

Word

Nice classes

1

Filing date

06/16/1994

Registration date

08/15/1995

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/24/2025

Last transaction

08/19/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

1987-08-00

First use in commerce

1987-08-00

Drawing code

1

Owner type

16

Owner location

CINCINNATI, OH, US

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

MOLECULAR RESEARCH CENTER, LLC
M. C. (pessoa física)
CINNA SCIENTIFIC, INC.
Molecular Research Center, Inc.
C. S. (pessoa física)

Representatives

Daniel M. Gurfinkel Dennemeyer & Associates, LLC

Technical classification

Nice Classes

Class 1

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

chemical reagent for isolating RNA from organic material in scientific or research use

Publications

History of USPTO decisions and trademark events.

24 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

08/19/2026

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

11/24/2025

RNL3

REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)

11/24/2025

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

11/24/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/24/2025

E89R

TEAS SECTION 8 & 9 RECEIVED

08/13/2025

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

08/15/2024

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

11/10/2014

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

11/10/2014

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

11/10/2014

E89R

TEAS SECTION 8 & 9 RECEIVED

11/07/2014

CFIT

CASE FILE IN TICRS

06/22/2007

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

12/29/2004

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

12/29/2004

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

11/22/2004

MAIL

PAPER RECEIVED

11/22/2004

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

09/05/2001

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

08/15/2001

R.PR

REGISTERED-PRINCIPAL REGISTER

08/15/1995

PUBO

PUBLISHED FOR OPPOSITION

05/23/1995

NPUB

NOTICE OF PUBLICATION

04/21/1995

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/22/1994

CNEA

EXAMINER'S AMENDMENT MAILED

12/15/1994

DOCK

ASSIGNED TO EXAMINER

12/07/1994

Continuous trademark protection

Get notified about every new filing that threatens RNAZOL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.